Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W R van Kuijk

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Seminars in Arthritis and Rheumatism|June 25, 2023
Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to womenR Raadsen, R Hansildaar, A W R van Kuijk, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 6, 2007
[Arthritis psoriatica]M A de Rie, A W R van Kuijk, A Y Goedkoop, et al.
Annals of the Rheumatic Diseases|January 17, 2009
TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockadeA W R van Kuijk, C A Wijbrandts, M Vinkenoog, et al.
Annals of the Rheumatic Diseases|May 27, 2006
Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatmentA W R van Kuijk, P Reinders-Blankert, T J M Smeets, et al.
Rheumatology (Oxford, England)|October 28, 2003
Early-onset polyarthritis as presenting feature of intestinal infection with Strongyloides stercoralisA W R van Kuijk, P J S M Kerstens, R M Perenboom, et al.
Annals of the Rheumatic Diseases|March 13, 2010
Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritisA W R van Kuijk, M de Groot, S O Stapel, et al.
Plos One|October 10, 2018
Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-upE H Vogelzang, R C F Hebing, M T Nurmohamed, et al.
Annals of the Rheumatic Diseases|July 24, 2008
A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissueA W R van Kuijk, D M Gerlag, K Vos, et al.
Annals of the Rheumatic Diseases|November 6, 2004
A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritisA D Fraser, A W R van Kuijk, R Westhovens, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Arthritis and Rheumatism|June 25, 2023
Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to womenR Raadsen, R Hansildaar, A W R van Kuijk, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 6, 2007
[Arthritis psoriatica]M A de Rie, A W R van Kuijk, A Y Goedkoop, et al.
Annals of the Rheumatic Diseases|January 17, 2009
TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockadeA W R van Kuijk, C A Wijbrandts, M Vinkenoog, et al.
Annals of the Rheumatic Diseases|May 27, 2006
Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatmentA W R van Kuijk, P Reinders-Blankert, T J M Smeets, et al.
Rheumatology (Oxford, England)|October 28, 2003
Early-onset polyarthritis as presenting feature of intestinal infection with Strongyloides stercoralisA W R van Kuijk, P J S M Kerstens, R M Perenboom, et al.
Annals of the Rheumatic Diseases|March 13, 2010
Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritisA W R van Kuijk, M de Groot, S O Stapel, et al.
Plos One|October 10, 2018
Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-upE H Vogelzang, R C F Hebing, M T Nurmohamed, et al.
Annals of the Rheumatic Diseases|July 24, 2008
A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissueA W R van Kuijk, D M Gerlag, K Vos, et al.
Annals of the Rheumatic Diseases|November 6, 2004
A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritisA D Fraser, A W R van Kuijk, R Westhovens, et al.
Pageof 1